The global aortic valve market is forecasted to attain revenue of $13.6 billion by 2025
New York, NY -- (SBWIRE) -- 08/21/2018 -- Aortic valve is a valve in the human heart between the left ventricle and the aorta. In case the aortic valve gets damaged, it is replaced or removed with an artificial aortic valve. The aortic valve replacement is done through open surgical procedures or minimally invasive surgical procedures. The different type of products used in aortic valve procedure includes transcatheter aortic valves and sutureless valves.
According to a research report by P&S Intelligence, the aortic valve market is witnessing steady growth, growing at a double digit rate between 2018-2025. Rising prevalance of valvular diseases, increasing preference for MISs, favorable reimbursement scenario and initiatives taking place for creating awareness about valve replacement are boosting the demand for aortic valves in the market.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/aortic-valve-market/report-sample
There are various initiatives being undertaken to increase the awareness and adoption for aortic valve replacement procedures. There are generally two major types of vlave replacement procedures, TAVE and AVR. TAVR is generally preferred for heart valve replacement as compared to surgical AVR. Thus, various initiatives are being undertaken to increase awareness about TAVR. The STS/ACC TVT registry is a collaborative initiative by Society of Thoracic Surgeons (STS) and American College of Cardiology to monitor real-world outcomes and patient safety pertaining to transcatheter valve repair and replacement surgeries. This registry is approved by CMS and provides insights about patient outcomes and guidelines for replacement and repair procedures.
Edwards Lifesciences Foundation is a sponsor of Valvular Disease Education Center and Ambassador Program, American Heart Association (AHA) in the U.S. The Heart Valve CareLine is a free patient hotline that provides professional assistance to patients. It also provides guidance on the insurance and reimbursement system.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=aortic-valve-market
The Valve for Life is an initiative in Europe launched by European Association of Percutaneous Cardiovascular Interventions in 2015. This initiative was aimed at improving access to transcatheter valve procedures in Europe. The purpose of this initiative was to raise awareness about valvular diseases, help patients to get increased access to TAVR, raise educational standards for healthcare practitioners, diminish gender and age discrimination in access to care, and reduce obstacles for therapy implementation. Key players in this market are undertaking several clinical studies for extending the interventional scope, analyzing safety of devices, and assessing subsequent treatment alternatives and mortality.
With a number of technological advancements taking place in the aortic valve market, the players are seeking approvals and introducing new and advanced valves to increase their market share. For instance, in March 2018, Abbott Laboratories received approval from USFDA for Masters HP15mm rotatable mechanical heart valve, that allow doctors to treat babies and toddlers in need of a mitral valve replacement.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)